Flavonoids and age-related disease: Risk, benefits and critical windows

Maturitas

Volumn 66, Issue 2, 2010, Pages 163-171

  Prasain, J K ^a   Carlson, S H ^b,c   Wyss, J M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c LUTHER COLLEGE   (United States)

Author keywords

Complimentary medicine; Dietary supplements; Kudzu; Metabolic syndrome; Soy

Indexed keywords

ANTHOCYANIN; APIGENIN; BERBERINE; CATECHIN; CINNAMON EXTRACT; COUMESTROL; DAIDZIN; FATTY ACID; FLAVONOID; GENISTIN; GINKGO BILOBA EXTRACT; GLUCOSE; GLYCITEIN; GRAPE SEED EXTRACT; INSULIN; ISOFLAVONE DERIVATIVE; KAEMPFEROL; KAVA; LIPID; NICOTINIC ACID; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYPHENOL DERIVATIVE; PROANTHOCYANIDIN DERIVATIVE; PUERARIN; QUERCETIN; SILIBININ; THEAFLAVIN; UNINDEXED DRUG; XUEZHIKANG;

ADJUVANT THERAPY; ALTERNATIVE MEDICINE; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOCHEMISTRY; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COGNITIVE DEFECT; COLORECTAL CANCER; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DRUG STRUCTURE; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAPE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; METABOLIC SYNDROME X; MUTAGENICITY; NEUROPROTECTION; NONHUMAN; OSTEOPOROSIS; PLANT SEED; PROSTATE CANCER; QUALITY CONTROL; REVIEW; RISK BENEFIT ANALYSIS; SOYBEAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; DIETARY SUPPLEMENTS; FLAVONOIDS; HUMANS; HYPOGLYCEMIC AGENTS; METABOLIC SYNDROME X; NEOPLASMS; NEURODEGENERATIVE DISEASES; OSTEOPOROSIS; PHYTOTHERAPY; QUALITY CONTROL;

ANIMALIA; PUERARIA MONTANA VAR. LOBATA; VITACEAE;

EID: 77952743304     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.01.010     Document Type: Review

References (125)

1. Barnes P.M., Powell-Griner E., McFann K., and Nahin R.L. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 27 May (343) (2004) 1-19
2. Radimer K.L. National nutrition data: contributions and challenges to monitoring dietary supplement use in women. J Nutr 133 June (6) (2003) 2003S-2007S
3. van Breemen R.B., Fong H.H., and Farnsworth N.R. Ensuring the safety of botanical dietary supplements. Am J Clin Nutr 87 February (2) (2008) 509S-513S
4. Weaver C.M., Barnes S., Wyss J.M., et al. Botanicals for age-related diseases: from field to practice. Am J Clin Nutr 87 February (2) (2008) 493S-497S
5. Anthony M.S., Clarkson T.B., Hughes Jr. C.L., Morgan T.M., and Burke G.L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126 January (1) (1996) 43-50
6. Barnes S., Grubbs C., Setchell K.D., and Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res 347 (1990) 239-253
7. Hedlund T.E., Maroni P.D., Ferucci P.G., et al. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J Nutr 135 June (6) (2005) 1400-1406
8. Harkness L.S., Fiedler K., Sehgal A.R., Oravec D., and Lerner E. Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Womens Health (Larchmt) 13 November (9) (2004) 1000-1007
9. Arjmandi B.H., Alekel L., Hollis B.W., et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126 January (1) (1996) 161-167
10. Miech R.A., Kim J., McConnell C., and Hamman R.F. A growing disparity in diabetes-related mortality U.S. trends, 1989-2005. Am J Prev Med 36 February (2) (2009) 126-132
11. Lawrence D.B., Allison W., Chen J.C., and Demand M. Improving medication adherence with a targeted, technology-driven disease management intervention. Dis Manag 11 June (3) (2008) 141-144
12. Wei H., Wei L., Frenkel K., Bowen R., and Barnes S. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer 20 1 (1993) 1-12
13. Zava D.T., and Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27 1 (1997) 31-40
14. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest Suppl 201 (1990) 3-23
15. Peterson G., and Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 7 October (10) (1996) 1345-1351
16. Piskula M.K., Yamakoshi J., and Iwai Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett 447 March (2/3) (1999) 287-291
17. Setchell K.D. Soy isoflavones-benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20 October (5 Suppl.) (2001) 354S-362S
18. Ader P., Block M., Pietzsch S., and Wolffram S. Interaction of quercetin glucosides with the intestinal sodium/glucose co-transporter (SGLT-1). Cancer Lett 162 January (2) (2001) 175-180
19. Cermak R., Landgraf S., and Wolffram S. Quercetin glucosides inhibit glucose uptake into brush-border-membrane vesicles of porcine jejunum. Br J Nutr 91 June (6) (2004) 849-855
20. Vedavanam K., Srijayanta S., O'Reilly J., Raman A., and Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE) 1. Phytother Res 13 November (7) (1999) 601-608
21. Cave N.J., Backus R.C., Marks S.L., and Klasing K.C. The bioavailability and disposition kinetics of genistein in cats. J Vet Pharmacol Ther 30 August (4) (2007) 327-335
22. Sfakianos J., Coward L., Kirk M., and Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127 July (7) (1997) 1260-1268
23. Prasain J.K., Xu J., Kirk M., Smith J.M., Sfakianos J., and Barnes S. Differential biliary excretion of genistein metabolites following intraduodenal and intravenous infusion of genistin in female rats. J Nutr 136 December (12) (2006) 2975-2979
24. Setchell K.D., Brown N.M., Desai P., et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131 April (4 Suppl.) (2001) 1362S-1375S
25. Prasain J.K., and Barnes S. Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus. Mol Pharm 4 November (6) (2007) 846-864
26. Prasain J.K., Jones K., Brissie N., Moore R., Wyss J.M., and Barnes S. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J Agric Food Chem 52 June (12) (2004) 3708-3712
27. Prasain J.K., Peng N., Moore R., Arabshahi A., Barnes S., and Wyss J.M. Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry. Phytomedicine 16 January (1) (2009) 65-71
28. Axelson M., Sjovall J., Gustafsson B.E., and Setchell K.D. Soya-a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 102 July (1) (1984) 49-56
29. Setchell K.D., Zhao X., Shoaf S.E., and Ragland K. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. J Nutr 139 November (11) (2009) 2037-2043
30. Setchell K.D., Zimmer-Nechemias L., Cai J., and Heubi J.E. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 68 December (6 Suppl.) (1998) 1453S-1461S
31. Setchell K.D., Brown N.M., and Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132 December (12) (2002) 3577-3584
32. Setchell K.D., and Cole S.J. Method of defining equol-producer status and its frequency among vegetarians. J Nutr 136 August (8) (2006) 2188-2193
33. Nathan B.M., and Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes 15 February (1) (2008) 21-29
34. Nelson R.A., and Bremer A.A. Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord November (2009) [Epub ahead of print]
35. Hoerger T.J., and Ahmann A.J. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes. J Manag Care Pharm 14 February (1 Suppl. C) (2008) S2-S14
36. Henneman P., Janssens A.C., Zillikens M.C., et al. Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome. J Intern Med August (2009) 26
37. Ledingham J.M. The vascular fault in hypertension: Byrom's work revisited. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. vol. 1 (1995), Raven Press Ltd., New York p. 37-53
38. Wilson P.W.F., and Kannel W.B. Hypertension, other risk factors, and the risk of cardiovascular disease. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. vol. 1 (1995), Raven Press Ltd., New York p. 99-114
39. Cohen E., Wheat M.E., Swiderski D.M., and Charney P. Hypertension in women. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. vol. 1 (1995), Raven Press Ltd., New York p. 159-69
40. Regitz-Zagrosek V., Lehmkuhl E., and Weickert M.O. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 95 March (3) (2006) 136-147
41. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 July (3) (2002) 321-333
42. Nagata C., Shimizu H., Takami R., Hayashi M., Takeda N., and Yasuda K. Association of blood pressure with intake of soy products and other food groups in Japanese men and women. Prev Med 36 June (6) (2003) 692-697
43. Nakamura M., Aoki N., Yamada T., and Kubo N. Feasibility and effect on blood pressure of 6-week trial of low sodium soy sauce and miso (fermented soybean paste). Circ J 67 June (6) (2003) 530-534
44. Welty F.K., Lee K.S., Lew N.S., and Zhou J.R. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch Intern Med 167 May (10) (2007) 1060-1067
45. Kuiper G.G., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 March (3) (1997) 863-870
46. Kuiper G.G., Lemmen J.G., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 October (10) (1998) 4252-4263
47. Liang Y.L., Teede H., Dalais F., and McGrath B.P. The effects of phytoestrogen on blood pressure and lipids in healthy volunteers. Zhonghua Xin Xue Guan Bing Za Zhi 34 August (8) (2006) 726-729
48. Rivas M., Garay R.P., Escanero J.F., Cia Jr. P., Cia P., and Alda J.O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 132 July (7) (2002) 1900-1902
49. Mahn K., Borras C., Knock G.A., et al. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J 19 October (12) (2005) 1755-1757
50. Li P., Ferrario C.M., Ganten D., and Brosnihan K.B. Chronic estrogen treatment in female transgenic (mRen2)27 hypertensive rats augments endothelium-derived nitric oxide release. Am J Hypertens 10 June (6) (1997) 662-670
51. Calhoun D.A., and Oparil S. The sexual dimorphism of high blood pressure. Cardiol Rev 6 November (6) (1998) 356-363
52. Fang Z., Carlson S.H., Chen Y.F., Oparil S., and Wyss J.M. Estrogen depletion induces NaCl-sensitive hypertension in female spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 281 December (6) (2001) R1934-R1939
53. Cho T.M., Peng N., Clark J.T., et al. Genistein attenuates the hypertensive effects of dietary NaCl in hypertensive male rats. Endocrinology 148 November (11) (2007) 5396-5402
54. Leifert W.R., and Abeywardena M.Y. Cardioprotective actions of grape polyphenols. Nutr Res 28 November (11) (2008) 729-737
55. Renaud S., and de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 June (8808) (1992) 1523-1526
56. Freedman J.E., Parker III C., Li L., et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103 June (23) (2001) 2792-2798
57. Peng N., Clark J.T., Prasain J., Kim H., White C.R., and Wyss J.M. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 289 September (30 (2005) R771-R775
58. Soares De M.R., Costa Viana F.S., Souza M.A., et al. Antihypertensive, vasodilator and antioxidant effects of a vinifera grape skin extract. J Pharm Pharmacol 54 November (11) (2002) 1515-1520
59. Peng N., Prasain J., Dai Y., et al. Chronic dietary kudzu isoflavones improve components of metabolic syndrome in stroke-prone spontaneously hypertensive rats. J Agric Food Chem 57 (2009) 7268-7273
60. Ferdowsian H.R., and Barnard N.D. Effects of plant-based diets on plasma lipids. Am J Cardiol 104 October (7) (2009) 947-956
61. McGowan M.P., and Proulx S. Nutritional supplements and serum lipids: does anything work?. Curr Atheroscler Rep 11 November (6) (2009) 470-476
62. Charland S.L., and Malone D.C. Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy. Curr Med Res Opin 26 February (2) (2010) 365-375
63. Becker D.J., Gordon R.Y., Halbert S.C., French B., Morris P.B., and Rader D.J. Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 150 June (12) (2009) 830-839
64. Anderson J.W., Johnstone B.M., and Cook-Newell M.E. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333 August (5) (1995) 276-282
65. Demonty I., Lamarche B., and Jones P.J. Role of isoflavones in the hypocholesterolemic effect of soy. Nutr Rev 61 June (6 Pt 1) (2003) 189-203
66. Demonty I., Lamarche B., Deshaies Y., and Jacques H. Role of soy isoflavones in the hypotriglyceridemic effect of soy protein in the rat. J Nutr Biochem 13 November (11) (2002) 671-677
67. Merz-Demlow B.E., Duncan A.M., Wangen K.E., et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 71 June (6) (2000) 1462-1469
68. Wangen K.E., Duncan A.M., Xu X., and Kurzer M.S. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73 February (2) (2001) 225-231
69. Taku K., Umegaki K., Sato Y., Taki Y., Endoh K., and Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85 April (4) (2007) 1148-1156
70. Allen J.K., Becker D.M., Kwiterovich P.O., Lindenstruth K.A., and Curtis C. Effect of soy protein-containing isoflavones on lipoproteins in postmenopausal women. Menopause 14 January (1) (2007) 106-114
71. Crawford P., Paden S.L., and Park M.K. Clinical inquiries: what is the dietary treatment for low HDL cholesterol?. J Fam Pract 55 December (12) (2006) 1076-1078
72. Allison D.B., Gadbury G., Schwartz L.G., et al. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Clin Nutr 57 April (4) (2003) 514-522
73. Orgaard A., and Jensen L. The effects of soy isoflavones on obesity. Exp Biol Med (Maywood) 233 September (9) (2008) 1066-1080
74. Saremi A., and Arora R. The cardiovascular implications of alcohol and red wine. Am J Ther 15 May (3) (2008) 265-277
75. de G.G., and Cerletti C. Wine and cardiovascular disease. Nutr Metab Cardiovasc Dis 11 August (4 Suppl.) (2001) 47-50
76. Hansen A.S., Marckmann P., Dragsted L.O., Finne N.I., Nielsen S.E., and Gronbaek M. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur J Clin Nutr 59 March (3) (2005) 449-455
77. Tsang C., Higgins S., Duthie G.G., et al. The influence of moderate red wine consumption on antioxidant status and indices of oxidative stress associated with CHD in healthy volunteers. Br J Nutr 93 February (2) (2005) 233-240
78. Nigdikar S.V., Williams N.R., Griffin B.A., and Howard A.N. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 68 August (2) (1998) 258-265
79. Guarda E., Godoy I., Foncea R., et al. Red wine reduces oxidative stress in patients with acute coronary syndrome. Int J Cardiol 104 September (1) (2005) 35-38
80. Pignatelli P., Ghiselli A., Buchetti B., et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188 September (1) (2006) 77-83
81. Micallef M., Lexis L., and Lewandowski P. Red wine consumption increases antioxidant status and decreases oxidative stress in the circulation of both young and old humans. Nutr J 6 (2007) 27
82. Ou H.C., Chou F.P., Sheen H.M., Lin T.M., Yang C.H., and Huey-Herng S.W. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Chim Acta 364 February (1/2) (2006) 196-204
83. Chrysohoou C., Panagiotakos D.B., Pitsavos C., et al. Effects of chronic alcohol consumption on lipid levels, inflammatory and haemostatic factors in the general population: the 'ATTICA' Study 1772. Eur J Cardiovasc Prev Rehabil 10 October (5) (2003) 355-361
84. Spaak J., Merlocco A.C., Soleas G.J., et al. Dose-related effects of red wine and alcohol on hemodynamics, sympathetic nerve activity, and arterial diameter. Am J Physiol Heart Circ Physiol 294 February (2) (2008) H605-H612
85. Shane-McWhorter L. Botanical dietary supplements and the treatment of diabetes: what is the evidence?. Curr Diab Rep 5 October (5) (2005) 391-398
86. Yin J., Gao Z., Liu D., Liu Z., and Ye J. Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294 January (1) (2008) E148-E156
87. Cefalu W.T., Ye J., Zuberi A., et al. Botanicals and the metabolic syndrome. Am J Clin Nutr 87 February (2) (2008) 481S-487S
88. Kirkham S., Akilen R., Sharma S., and Tsiami A. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab 11 December (12) (2009) 1100-1113
89. Sheng X., Zhang Y., Gong Z., Huang C., and Zang YQ. Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res (2008) 581348
90. Qin B., Polansky M.M., and Anderson R.A. Cinnamon extract regulates plasma levels of adipose-derived factors and expression of multiple genes related to carbohydrate metabolism and lipogenesis in adipose tissue of fructose-fed rats. Horm Metab Res November (2009) [Epub ahead of print]
91. Nahas R., and Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 55 June (6) (2009) 591-596
92. Yamaguchi M. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 126 November (11) (2006) 1117-1137
93. Messina M., Ho S., and Alekel D.L. Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data. Curr Opin Clin Nutr Metab Care 7 November (6) (2004) 649-658
94. Atteritano M., Marini H., Minutoli L., et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 92 August (8) (2007) 3068-3075
95. Marini H., Minutoli L., Polito F., et al. Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann Intern Med 146 June (12) (2007) 839-847
96. Weaver C.M., Martin B.R., Jackson G.S., et al. Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. J Clin Endocrinol Metab 94 October (10) (2009) 3798-3805
97. Reinwald S., and Weaver C.M. Soy isoflavones and bone health: a double-edged sword?. J Nat Prod 69 March (3) (2006) 450-459
98. Bittner V. Menopause and cardiovascular risk cause or consequence?. J Am Coll Cardiol 47 May (10) (2006) 1984-1986
99. Deng G., and Cassileth B.R. To what extent do cancer patients use complementary and alternative medicine?. Nat Clin Pract Oncol 2 October (10) (2005) 496-497
100. Suzuki T., Matsuo K., Tsunoda N., et al. Effect of soybean on breast cancer according to receptor status: a case-control study in Japan. Int J Cancer 123 October (7) (2008) 1674-1680
101. Dai Q., Shu X.O., Jin F., et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 85 August (3) (2001) 372-378
102. Touillaud M.S., Pillow P.C., Jakovljevic J., et al. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 51 2 (2005) 162-169
103. Allred C.D., Ju Y.H., Allred K.F., Chang J., and Helferich W.G. Dietary genistin stimulates growth of estrogen-dependent breast cancer tumors similar to that observed with genistein. Carcinogenesis 22 October (10) (2001) 1667-1673
104. Allred C.D., Allred K.F., Ju Y.H., Virant S.M., and Helferich W.G. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res 61 July (13) (2001) 5045-5050
105. Yang G., Shu X.O., Li H., et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 16 June (6) (2007) 1219-1223
106. Howells L.M., Mitra A., and Manson M.M. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines. Int J Cancer 121 July (1) (2007) 175-183
107. Nandakumar V., Singh T., and Katiyar S.K. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269 October (2) (2008) 378-387
108. Cassileth B.R., Heitzer M., and Wesa K. The public health impact of herbs and nutritional supplements. Pharm Biol 47 August (8) (2009) 761-767
109. Joseph J.A., Shukitt-Hale B., Denisova N.A., et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 19 September (18) (1999) 8114-8121
110. Coleman P., Finch C., and Joseph J. The need for multiple time points in aging studies [editorial]. Neurobiol Aging 11 January (1) (1990) 1-2
111. Joseph J.A., Shukitt-Hale B., Denisova N.A., et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 18 October (19) (1998) 8047-8055
112. Wharton W., Dowling M., Khosropour C.M., Carlsson C., Asthana S., and Gleason C.E. Cognitive benefits of hormone therapy: cardiovascular factors and healthy-user bias. Maturitas 64 November (3) (2009) 182-187
113. Resnick S.M., Espeland M.A., An Y., et al. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin Endocrinol Metab 94 November (11) (2009) 4152-4161
114. Eng E.T., Ye J., Williams D., et al. Suppression of estrogen biosynthesis by procyanidin dimers in red wine and grape seeds. Cancer Res 63 December (23) (2003) 8516-8522
115. Agarwal C., Sharma Y., Zhao J., and Agarwal R. A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation. Clin Cancer Res 6 July (7) (2000) 2921-2930
116. Sharma G., Tyagi A.K., Singh R.P., Chan D.C., and Agarwal R. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Res Treat 85 May (1) (2004) 1-12
117. Aldini G., Carini M., Piccoli A., Rossoni G., and Facino R.M. Procyanidins from grape seeds protect endothelial cells from peroxynitrite damage and enhance endothelium-dependent relaxation in human artery: new evidences for cardio-protection. Life Sci 73 October (22) (2003) 2883-2898
118. Meng S., Cason G.W., Gannon A.W., Racusen L.C., and Manning Jr. R.D. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41 June (6) (2003) 1346-1352
119. Kishi T., Hirooka Y., Kimura Y., Ito K., Shimokawa H., and Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109 May (19) (2004) 2357-2362
120. Zhang Y., Croft K.D., Mori T.A., Schyvens C.G., McKenzie K.U., and Whitworth J.A. The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 17 March (3) (2004) 260-265
121. Wyss J.M., Kadish I., and Van Groen T. Age-related decline in spatial learning and memory: attenuation by captopril. Clin Exp Hypertens 25 October (7) (2003) 455-474
122. Sridar C., Goosen T.C., Kent U.M., Williams J.A., and Hollenberg P.F. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. Drug Metab Dispos 32 June (6) (2004) 587-594
123. Mohamed M.E., and Frye R.F. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids. Drug Metab Dispos November (2009)
124. Jhoo J.W., Ang C.Y., Heinze T.M., et al. Identification of C-glycoside flavonoids as potential mutagenic compounds in kava. J Food Sci 72 March (2) (2007) C120-C125
125. Prasain J.K., Jones K., Kirk M., et al. Profiling and quantification of isoflavonoids in kudzu dietary supplements by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. J Agric Food Chem 51 July (15) (2003) 4213-4218